COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

ADC Clinical/Commercial Manufacturing

We are a world-leading multi-product facility for clinical and commercial manufacturing of antibody-drug conjugates (ADCs) and other bioconjugates. Besides, we have a robust process development, characterization, optimization, and scale-up expertise supporting successful GMP manufacturing.

#1 FOR ADC GMP MANUFACTURE 

Piramal has been manufacturing ADCs for over 15 years.

Facilities

  • Three clinical and commercial-scale GMP manufacturing suites
  • Successfully audited by US FDA, MHRA, PMDA, ANVISA, and Turkish Ministry of Health
  • All suites can support chromatographic purification capabilities
  • Batch sizes up to ca. 3kg input mAb
  • Up to 1000L reactive volume capability depending on the complexity
  • Dedicated or single-use product-contact manufacturing components
  • Handling capability for derivatives or analogs of highly potent cytotoxic agents or natural and synthetic origin: auristatin, maytansanoids, duocarmycins, and others
  • Containment to 10ng/m3 OEL

#1 For A Reason

  • Over 900 ADC batches manufactured
  • Over 500 GMP batches manufactured
  • Over 190 different conjugates from 120 antibodies
  • Over 60 different toxin/toxin-linker system
  • Over 35 different ADCs manufactured to GMP
  • Over 200 commercial batches manufactured